Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists

Bioorganic & Medicinal Chemistry
2017.0

Abstract

A series of GPR119 agonists based on a 5-nitropyrimidine scaffold bearing endo-azabicyclic substituents were synthesized and evaluated for their GPR119 agonistic activities. Most compounds exhibited much stronger EC50 values than that of oleoylethanolamide (OEA). Among them, derivatives from endo-azabicyclic alcohols displayed more potent GPR119 agonistic activities than compounds with endo-azabicyclic amines. Especially the optimized compounds (6, 7, 8, 12, 17) were shown to have potent biological activities and were identified as full agonists. Isopropyl carbamate compound 8 synthesized from endo-azabicyclic alcohol was observed to have the best EC50 value (0.6nM). Generally 2-fluoro substitution of the aryl group at the C4 position of 5-nitropyrimidine scaffold resulted in the increase of biological activity.

Knowledge Graph

Similar Paper

Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist
Bioorganic & Medicinal Chemistry Letters 2017.0
Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes
Bioorganic & Medicinal Chemistry 2018.0
Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists
Bioorganic & Medicinal Chemistry 2013.0
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists
Bioorganic & Medicinal Chemistry Letters 2020.0
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2020.0
Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists
Bioorganic & Medicinal Chemistry Letters 2014.0